5,6-dihydroxyindole-2-carboxylic acid oxidase (284-298)

5,6-Dihydroxyindole-2-carboxylic acid oxidase (284-298) is a synthetic peptide fragment corresponding to a specific sequence within the oxidase enzyme that catalyzes the oxidation of 5,6-dihydroxyindole-2-carboxylic acid, a key intermediate in melanin biosynthesis. As a peptide derivative, it serves as a valuable biochemical tool for probing the structure-function relationships of oxidase enzymes involved in pigment formation pathways. Its defined sequence allows researchers to investigate the role of discrete regions within the parent protein, facilitating a deeper understanding of enzymatic mechanisms, substrate specificity, and protein-protein interactions in melanogenic processes.

Enzyme activity studies: The peptide fragment is widely utilized in enzymology research to dissect the catalytic properties of the full-length oxidase. By isolating the 284-298 region, scientists can examine its contribution to substrate binding and electron transfer during the oxidation of indole derivatives. Such studies enable the identification of critical residues involved in catalysis and support the development of mechanistic models for the enzyme's function within melanin biosynthesis.

Epitope mapping and antibody production: Due to its well-defined sequence, the peptide serves as an excellent antigen for generating site-specific antibodies against the oxidase. These antibodies are valuable tools for detecting and quantifying the enzyme in various biological samples, supporting immunochemical assays such as Western blotting, immunoprecipitation, and immunohistochemistry. Furthermore, the peptide aids in epitope mapping experiments that elucidate antibody binding sites, thereby enhancing the specificity and sensitivity of analytical techniques targeting melanogenic enzymes.

Protein-protein interaction assays: The 5,6-dihydroxyindole-2-carboxylic acid oxidase (284-298) fragment is instrumental in studies aimed at characterizing interactions between the oxidase and its regulatory partners or substrates. By employing the peptide in binding assays, researchers can identify molecular determinants of interaction, map contact regions, and assess the effects of mutations or modifications on complex formation. Insights gained from these experiments inform broader investigations into the regulation of pigment biosynthetic pathways.

Peptide-based inhibitor screening: The defined structure of the peptide fragment makes it a suitable scaffold for screening and designing inhibitors that modulate oxidase activity. In drug discovery and biochemical research, it can be used to assess the efficacy of candidate molecules that bind to or block the active site or allosteric regions represented within the 284-298 sequence. Such applications contribute to the identification of novel modulators of melanin synthesis, which are of interest in pigmentation biology and related fields.

Structural and conformational analyses: The peptide's sequence provides a model system for biophysical studies investigating the secondary and tertiary structural features of the oxidase. Techniques such as circular dichroism spectroscopy, NMR, and X-ray crystallography can be employed to elucidate the folding properties and conformational dynamics of the fragment. These structural insights are critical for understanding how specific regions of the enzyme contribute to its overall stability, function, and interaction with substrates or inhibitors.

1. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling